Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog

References

• DjafariFLeskMRHarasymowyczPJDesjardinsDLachaineJDeterminants of adherence to glaucoma medical therapy in a long-term patient populationJ Glaucoma200918323824319295380
   PubMed Web of Science ®Google Scholar
• Kawai-TsuboiNKawaiMMinamiYYoshidaAA study of the association between patterns of eye drop prescription and medication usage in glaucoma subjectsJ Glaucoma6252013 Epub ahead of print
   Web of Science ®Google Scholar
• StrohmaierKSnyderEDuBinerHAdamsonsIThe efficiency and safety of the dorzalamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study GroupOphthalmology199810510193619449787367
   PubMed Web of Science ®Google Scholar
• HigginbothamEJFeldmanRStilesMDubinerHFixed Combination Investigative GroupLatanoprost and timolol combination therapy vs monotherapy: one-year randomized trialArch Ophthalmol2002120791592212096962
   PubMed Web of Science ®Google Scholar
• BarnebeyHSOrengo-NaniaSFlowersBESafety and efficiency of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solutionAm J Ophthalmol200514011715990081
   PubMed Web of Science ®Google Scholar
• DiestelhorstMLarssonLIA 12-week, randomized double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual componentsOphthalmology20061131707616263174
   PubMed Web of Science ®Google Scholar
• HommerAGanfort Investigators Group IA double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertensionEur J Ophthalmol2007171536217294383
   PubMed Web of Science ®Google Scholar
• NagayamaMNakajimaTOnoJSafety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol201413821922824531757
   PubMedGoogle Scholar
• KitazawaYAzumaIIwataKDorzolamide, a topical carbonic anhydrase inhibitor: a two-week dose-response study in patients with glaucoma or ocular hypertensionJ Glaucoma19943427527919920609
   PubMedGoogle Scholar
• MundorfTKRauchmanSHWilliamsRDNotivolRBrinzolamide/Timolol Preference Study GroupA patient preference comparison of Azarga (brinzolamide/timolol fixed combination) vs Cosopt (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol20082362362819668763
   PubMedGoogle Scholar
• ManniGDenisPChewPThe safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertensionJ Glaucoma200918429323019365194
   PubMed Web of Science ®Google Scholar
• RossiGCPasinettiGMSandoloFBordinMBianchiPEFrom dorzolamide 2%/timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month, multicenter, open-label tolerability switch studyExpert Opin Pharmacother201112162425243121679090
   PubMed Web of Science ®Google Scholar
• LanzlIRaberTEfficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practiceClin Ophthalmol2011529129821468336
   PubMedGoogle Scholar
• AugerGARaynorMLongstaffSPatient perspectives when switching from Cosopt® (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapyClin Ophthalmol201262059206223271886
   PubMedGoogle Scholar
• ChengJWChengSWGaoLDLuGCWeiRLIntraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysisPLoS One201279e4507923028770
   PubMed Web of Science ®Google Scholar
• Sezgin AkçayBÝGüneyEBozkurtKTUnlüCAkçaliGThe safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertensionJ Ocul Pharmacol Ther2013291088288624180628
   PubMed Web of Science ®Google Scholar
• SanseauASampaolesiJSuzukiERJrLopesJFBorelHPreference for a fixed combination of brinzolamide/timolol versus dorzolamide/timolol among patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol2013735736223440904
   PubMedGoogle Scholar
• MiyataKAmanoSSawaMA novel grading method for superficial punctate keratopathy magnitude and its correlation with corneal epithelial permeabilityArch Ophthalmol2003121111537153914609908
   PubMedGoogle Scholar
• NagaiNMuraoTOeKItoYOkamotoNShimomuraYAn in vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)Yakugaku Zasshi20111316985991 Japanese21628988
   PubMed Web of Science ®Google Scholar
• FiratPGSamdanciEDoganarySCavdarMSahinNGunduzAShort-term effect of topical brinzolamide-timolol fixed combination on ocular surface of glaucoma patientsInt J Ophthalmol20125671471823275906
   PubMed Web of Science ®Google Scholar
• NebbiosoMEvangelistaMLibrandoADi BlasioDPescosolidoNFixed topical combinations in glaucomatous patients and ocular discomfortExpert Opin Pharmacother201213131829183522770575
   PubMed Web of Science ®Google Scholar
• AyakiMYaguchiSIwasawaAKoideRCytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cellsClin Experiment Ophthalmol200836655355918954319
   PubMed Web of Science ®Google Scholar
• IesterMTelaniSFrezzottiPBeta-Blocker Study GroupOcular surface changes in glaucomatous patients treated with and without preservatives beta-blockersJ Ocul Pharmacol Ther201430647648124787056
   PubMed Web of Science ®Google Scholar
• BarabinoSAntonelliSCimboliniNMauroVBauzinMThe effect of preservatives and anti-glaucoma treatments on the ocular surface of mice with dry eyeInvest Ophthalmol Vis Sci201455106499650425205861
   PubMed Web of Science ®Google Scholar
• PozarowskaDPozarowskiPDarzynkiewiczZCytometric assessment of cytostatic and cytotoxic effects of topical glaucoma medications on human epithelial corneal line cellsCytometry B Clin Cytom201078213013719834965
   PubMed Web of Science ®Google Scholar
• HiraokaTDaitoMOkamotoFKiuchiTOshikaTContrast sensitivity and optical quality of the eye after instillation of timolol maleate gel-forming solution and brinzolamide ophthalmic suspensionOphthalmology2010117112080208720656353
   PubMed Web of Science ®Google Scholar
• AritaRItohKMaedaSEffects of long-term topical anti-glaucoma medications on meibomian glandsGraefes Arch Clin Exp Ophthalmol20122508181185
   Web of Science ®Google Scholar
• AgnifiliLFasanellaVCostagliolaCIn vivo confocal microscopy of meibomian glands in glaucomaBr J Ophthalmol201397334334923269683
   PubMed Web of Science ®Google Scholar
• SchiffmanRMChristiansonMDJacobsenGHirschJDReisBLReliability and validity of the Ocular Surface Disease IndexArch Ophthalmol2000118561562110815152
   PubMedGoogle Scholar